APA (7th ed.) Citation

A, N., J, M., A, B., S, B., K, D., N, F., . . . Y, D. (2015). The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: A systematic review and economic evaluation. Health technology assessment (Winchester, England), 19(87), i. https://doi.org/10.3310/hta19870

Chicago Style (17th ed.) Citation

A, Nicholson, Mahon J, Boland A, Beale S, Dwan K, Fleeman N, Hockenhull J, and Dundar Y. "The Clinical Effectiveness and Cost-effectiveness of the PROGENSA® Prostate Cancer Antigen 3 Assay and the Prostate Health Index in the Diagnosis of Prostate Cancer: A Systematic Review and Economic Evaluation." Health Technology Assessment (Winchester, England) 19, no. 87 (2015): i. https://doi.org/10.3310/hta19870.

MLA (9th ed.) Citation

A, Nicholson, et al. "The Clinical Effectiveness and Cost-effectiveness of the PROGENSA® Prostate Cancer Antigen 3 Assay and the Prostate Health Index in the Diagnosis of Prostate Cancer: A Systematic Review and Economic Evaluation." Health Technology Assessment (Winchester, England), vol. 19, no. 87, 2015, p. i, https://doi.org/10.3310/hta19870.